Amir Fathi, M.D.
Physician Investigator (Cl)
Cancer Center, Mass General Research Institute
Assistant In Medicine
Hematology-Oncology, Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
|MD Yale University School of Medicine 2004|
My research is focused on the development and clinical translation of novel therapies for acute leukemias.
I currently lead multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies.
I have a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.